FOSAMAX 70 mg, tablet 4 tablets
Active ingredients: Alendronic acid, Alendronate sodium trihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Tablet4 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FOSAMAX 70 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) aluminium de 4 comprimé(s)
- Marketing authorisation holder
- ORGANON FRANCE
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Ostéoporose postménopausique pour réduire le risque de fractures vertébrales et de hanche :<br>. patientes ayant fait une fracture par fragilité osseuse <br>. en l'absence de fracture, patientes ayant une diminution importante de la densité osseuse selon évaluation clinique. ; JOURNAL OFFICIEL ; 15/10/02
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 30 Aug 2002
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62158815CIP73595637CIP133400935956378Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ALENDRONATE MONOSODIQUE TRIHYDRATÉcomprimé | — | SA |
| ACIDE ALENDRONIQUEcomprimé | 70 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.